Is This the Only Stock Left to Buy Here?
In today's edition, Austin looks at CVS (NYS: CVS) . There is a lot of danger in the retail pharmacy space, and none of the big players looks great. Rite Aid has very low operating margins and an estimate for same-store sales growth of -0.05% to 1%. Walgreen expanded with its recent $6.7 billion acquisition of a U.K.-based drugstore, but it still needs to shore up domestically after its Express Scripts fallout. That leaves CVS, which has its own PBM, as the only company with a big advantage over its competition.
The retail pharmacy space isn't the only sector characterized by fear and uncertainty. Finance is as well. But unlike the retail space, some of the best opportunities over the next few years can be found there. In fact, the sector is home to The Stocks Only the Smartest Investors Are Buying. You can learn about it, and more, in our exclusive free report. Just click here to keep reading.
The article Is This the Only Stock Left to Buy Here? originally appeared on Fool.com.
Austin Smith has no positions in the stocks mentioned above. The Motley Fool has no positions in the stocks mentioned above. Motley Fool newsletter services recommend Express Scripts. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
